Glaucoma is a leading cause of blindness, characterized by retinal ganglion cell (RGC) loss and optic nerve (ON) damage. Cumulative evidence suggests glial cell involvement in the degeneration of the ON and RGCs. We analyzed the contribution of microglial reactivity to early axoglial alterations of the ON in an induced model of ocular hypertension. For this purpose, vehicle or chondroitin sulfate (CS) were weekly injected into the eye anterior chamber from Wistar rats for different intervals. The amount of Brn3a(+) RGC significantly decreased in CSinjected eyes for 10 and 15 (but not 6) weeks. A reduction in anterograde transport of b-subunit cholera toxin was observed in the superior colliculus and the lateral geniculate nucleus contralateral to CS-injected eyes for 6 and 15 weeks. A disruption of cholera toxin b-subunit transport was observed at the proximal myelinated ON. A significant decrease in phosphorylated neurofilament heavy chain immunoreactivity, an increase in ionized calcium-binding adaptor molecule 1(+), ED1(+) (microglial markers), and glial fibrillary acidic protein (astrocytes) (+) area, and decreased luxol fast blue staining were observed in the ON at 6 and 15 weeks of ocular hypertension. Microglial reactivity involvement was examined through a daily treatment with minocycline (30 mg/kg, i.p.) for 2 weeks, after 4 weeks of ocular hypertension. Minocycline prevented the increase in ionized calcium-binding adaptor molecule 1(+), ED-1(+), and glial fibrillary acidic protein(+) area, the decrease in phosphorylated neurofilament heavy-chain immunoreactivity and luxol fast blue staining, and the deficit in anterograde transport induced by 6 weeks of ocular hypertension. Thus, targeting microglial reactivity might prevent early axoglial alterations in the glaucomatous ON.
Glaucoma, a leading cause of blindness, is a progressive optic neuropathy characterized by specific visual field defects associated with the loss of retinal ganglion cells (RGCs) and damage to the optic nerve head (ONH) (Quigley 2011) . Increased intraocular pressure (IOP) is the most accepted risk factor for developing glaucomatous neuropathy. In fact, current therapy in glaucoma is focused on decreasing IOP by pharmacological or surgical means, or with laser treatment. However, despite successful IOP control, many patients continue to lose vision (Musch et al. 2009 ), and it is becoming increasingly clear that the exclusive focus on IOP is not sufficient. To develop new treatments, it is necessary to have a better understanding of the mechanisms that lead to glaucomatous neuropathy. Considering the limitations of working with humans, animal models are a key tool for understanding pathogenic mechanisms of glaucoma. Several groups have established different models of glaucoma in rats (reviewed by Ishikawa et al. 2015) , all of which have both advantages and disadvantages. We have developed an experimental model of glaucoma in rats through weekly injections of chondroitin sulfate (CS) in the eye anterior chamber (Belforte et al. 2010) . Acute or chronic injections of CS significantly increase IOP as compared with vehicleinjected eye. Moreover, a significant decrease in flash visualevoked potentials was found in eyes receiving CS for 6 and 10 weeks, and a significant RGC and optic nerve (ON) axon loss was demonstrated in eyes injected with CS for 10 weeks, supporting the contention that intracameral injections of CS reproduce central characteristics of human primary open-angle glaucoma (Belforte et al. 2010) .
The degeneration of RGC soma that leads to glaucomatous vision loss has been attributed to an initial injury to axons within the ONH (Burgoyne et al. 1995; Howell et al. 2007; Soto et al. 2008; Chidlow et al. 2011; Morrison et al. 2011) . In addition, defects in axonal transport have been reported as one of the earliest alterations in glaucoma (reviewed by Calkins 2012) . In that sense, progressive decline of anterograde axonal transport function , and retrograde transport deficits (Jakobs et al. 2005; Buckingham et al. 2008) , preceding ON axon loss have been reported in different animal models of glaucoma. Although axonal transport interruption was originally attributed to constriction of the ONH as RGC axons exit the eye Quigley et al. 2000) , more recent reports suggest subtler intra-axonal mechanisms ; reviewed by Crish and Calkins 2011) . Moreover, several studies have demonstrated that the progressive degeneration of ON axons and RGCs in glaucoma is accompanied by significant changes of different retina and ON glial cell types (Hernandez 2000; Yuan and Neufeld 2001; Naskar et al. 2002; Neufeld and Liu 2003; Libby et al. 2005; Nakazawa et al. 2006; Schlamp et al. 2006; Crish et al. 2010; Sappington et al. 2010; Bosco et al. 2011 Bosco et al. , 2015 Sun and Jakobs 2012; Qu and Jakobs 2013) . Although the precise interaction among glial cells, neurons, and axons is still unknown, it is possible that glial cells, particularly microglia, become directly pathogenic to axons. In the DBA/2J mouse, an established model of inherited, age-related pigmentary glaucoma , microglial cells become activated prior to detectable RGC loss (Bosco et al. 2011 (Bosco et al. , 2015 . In the same experimental model, it has been shown that the extent of microglia activation at the ONH is proportional to the severity of ON degeneration (Bosco et al. 2015) . Moreover, it was shown that a long-term treatment of DBA/2J mice with minocycline which suppresses early microglial activation, significantly improves neuronal retrograde tracing from the superior colliculus (SC), the main retinal synaptic target in rodents (Bosco et al. 2008) . Furthermore, minocycline delays RGC death in an experimental model of glaucoma in rats (Levkovitch-Verbin et al. 2006) . However, the involvement of microglial reactivity in the early anterograde transport deficit and axoglial alterations of the ON induced by experimental glaucoma has not been previously examined. In that context, the aim of the present report was to analyze the contribution of microglial reactivity on early axoglial alterations of the ON in a rat glaucoma model induced by CS.
Materials and methods

Animals
Male Wistar rats (average weight 250 AE 40 g) from our own colony derived from a stock supplied by Charles River Breeding Laboratories (Wilmington, MA, USA) were housed in a standard animal room with food and water ad libitum under controlled temperature (21 AE 2°C) and humidity conditions. The room was lighted by fluorescent lights that were turned on (at 8.00 AM) and off (at 8.00 PM) automatically every 12 h. All animal procedures were performed in strict accordance with the National Institutes of Health guide for the care and use of laboratory animals. Rats were anesthetized with an intraperitoneal injection of ketamine hydrochloride (50 mg/kg) and xylazine hydrochloride (7 mg/kg). A total number of 85 rats were used for the experiments, distributed as follows: 15 animals for Brn3a quantification, 30 animals for cholera toxin b-subunit (CTB) detection (including minocyclinetreated rats), 20 animals for luxol fast blue experiments, and 20 animals for immunohistochemistry experiments (including minocycline-treated animals). The experimental procedures reported here were approved by the Animal Care Committee of the Center for Pharmacological and Botanical Studies, National Research Council, and by the Institutional Committee for the Care and Use of Laboratory Animals (CICUAL) from the School of Medicine, University of Buenos Aires. Animals were identified by earmark numbers, and the randomizing protocol was performed by assigning them to each treatment, using a random number generator (http:// www.randomizer.org/form.htm).
Experimental model of glaucoma
Weekly injections of CS were performed as described previously (Belforte et al. 2010) . Briefly, under a surgical microscope (OMNI MDU XY; Carl Zeiss, Thornwood, NY, USA) 20 lL of 40% CS (catalog # C9819; Sigma Chemical Co., St. Louis, MO, USA) in saline solution were injected into one eye instilled with 0.5% proparacaine hydrochloride, using a Hamilton syringe with a 30G needle, while the same volume of vehicle was injected in the contralateral eye. The content of the syringe was slowly and progressively injected to avoid ocular ischemia and lens damage. Rats that developed cataract or phthisis bulbi (four animals) were excluded from the experiments.
IOP assessment IOP was assessed each week, as described previously (Belforte et al. 2010) . Briefly, animals were wrapped in a small towel, and IOP readings were obtained with a TonoPen XL (Mentor, Norwell, MA, USA) contacting firmly the cornea. TonoPen readings differed less than 10% (standard error). The mean of these readings was recorded as the IOP for each eye. Mean values from each rat were averaged, and the resultant mean value was used to compute the group mean IOP AE SE. IOP determinations were performed between 11.00 and 12.00 h to correct for diurnal variations in this parameter (Moreno et al. 2005) .
Cholera toxin b-subunit transport studies Animals were anesthetized, and a drop of proparacaine (0.5%, Anestalcon; Alcon Laboratories, Buenos Aires, Argentina) was topically administered for local anesthesia. Four microliters of 0.1% CTB conjugated to Alexa 488 (Cat. #: c22841; Molecular Probes, Eugene, OR, USA) in sterile saline solution were injected into the vitreous, using a 30G Hamilton syringe (Hamilton, Reno, NV, USA), as reported previously (Dorfman et al. 2013) . The injections were applied 1 mm from the limbus, and the needle was left in the eye for 30 s to prevent volume loss. At 3 days post-injection, rats were anesthetized and intracardially perfused with 4% paraformaldehyde in phosphate buffer (PBS), pH 7.4. Brains were carefully removed, post-fixed overnight at 4°C, cryoprotected in sucrose solutions (10%, 20%, and 30%), and embedded in OCT compound (Crioplast â ; Biopack, Buenos Aires, Argentina). Coronal sections (40 lm) were obtained at the level of lateral geniculate nucleus (LGN) and SC using a freezing microtome CM 1850 (Leica, Wetzlar, Germany) and observed under an epifluorescence microscope (BX50; Olympus, Duarte, CA, USA). Additionally, to determine the site of transport disruption, eyeballs together with 2 mm of the ON were carefully dissected and processed similarly to brains, with the cornea and lens removed before cryoprotecting the eye in a sucrose gradient. In order to obtain longitudinal ON sections and transverse retinal sections, eyecups were sagittally sectioned at the level of the ONH (15 lm thickness) and mounted in superfrost microscope slides (Erie Scientific Company, Portsmouth, NH, USA).
Histological evaluation of the ON Deeply anesthetized animals were intracardially perfused with saline solution, followed by 4% paraformaldehyde in PBS (pH 7.4). Eyes and ON samples from the ONH near the optic chiasm were obtained and post-fixed for 24 h in the same fixative solution at 4°C. After several washes, the samples were dehydrated, cleared in n-butanol, and embedded in paraffin wax. Serial transverse sections (5 lm) of the myelinated proximal ON were obtained using a microtome (Leica; Leica Microsystems, Buenos Aires, Argentina).
Immunohistochemical studies
The following antibodies were used: a goat anti-Brn3a (AB Registry ID: AB_2167511, 1 : 500; Santa Cruz Biotechnology, Buenos Aires, Argentina), a mouse monoclonal anti-phosphorylated neurofilament heavy chain (pNFH) (AB Registry ID: AB_448147, 1 : 1000; Abcam, Inc., Buenos Aires, Argentina), a goat antiionized calcium-binding adaptor molecule 1 (Iba-1) (AB Registry ID: AB_2224402, 1 : 500; Abcam, Inc.), a mouse anti-ED1 (AB Registry ID: AB_1141557, 1 : 200; Abcam, Inc.), a mouse monoclonal anti-glial fibrillary acidic protein (GFAP) conjugated to Cy3 (AB Registry ID: AB_476889, 1 : 1200; Sigma Chemical Co.), a rabbit polyclonal anti-myelin basic protein (myelin basic protein, MBP, 1 : 1000, kindly supplied by Dr. Campagnoni, Mental Retardation Research Center, University of California, Los Angeles, CA, USA), a donkey anti-goat secondary antibody conjugated to Alexa 568 (AB Registry ID: AB_2636995, 1 : 500; Life Technologies, Grand Island, NY, USA), a goat anti-mouse and a donkey anti-mouse secondary antibodies conjugated to Alexa 488 (Cat. #: ab150105, 1 : 500; Molecular Probes, Buenos Aires, Argentina), and a donkey anti-rabbit secondary antibody conjugated to Alexa 568 (Cat. # ab175470, 1 : 500; Molecular Probes).
For ON immunohistochemical studies, proximal ON transversal sections were deparaffinized, hydrated, and antigen retrieval was performed (except for MBP immunodetection) with citrate buffer (pH 6.3) for 30 min at 90°C. After permeabilization with 0.1% Triton X-100 in 0.1 mol/L PBS for 10 min, sections were unspecifically blocked with normal horse serum (2%) for 1 h, followed by incubation with primary antibodies overnight at 4°C. Then, samples were incubated with secondary antibodies for 2 h at 25°C, and mounted with fluorescent mounting medium (Dako, Glostrup, Denmark), and viewed at 2009 magnification under a fluorescence microscope. To confirm specificity, primary antibodies were avoided in some sections.
For MBP immunodetection, longitudinal optic nerve cryostat sections were obtained and immersed in 5% normal horse serum, 0.3% Triton X-100 in 0.1 M PBS for 2 h, for unspecific blockade and permeabilization, and then incubated overnight at 4°C with primary antibody diluted in 2% normal horse serum 0.1% Triton X-100 in 0.1 M PBS.
For immunodetection of Brn3a, 15 lm thickness retinal sections were obtained using a freezing microtome, and mounted in superfrost microscope slides. For antigen retrieval, the same protocol described above was followed. All images were captured using identical exposure time, under an epifluorescence microscope (BX50; Olympus, Tokyo, Japan) connected to a video camera (3CCD; Sony, Tokyo, Japan), attached to a computer running image analysis software (Image-Pro Plus; Media Cybernetics, Inc., Bethesda, MD, USA). Immunofluorescence studies were performed analyzing comparative digital images from different samples with the same brightness, and contrast settings.
Luxol fast blue staining
Deparaffinized transversal proximal ON sections were re-hydrated and incubated with 0.1% luxol fast blue (LFB; Biopack) in acidified 95% ethanol overnight at 60°C. Li 2 CO 3 (0.01%) for 5 min in 0.5% neutral red (Biopack) was used for differentiation and nuclei counter-staining. Sections were mounted and viewed under a light microscope (Nikon Eclipse E400, Tokyo, Japan). Light microscopic images (2009) were digitally captured via a Nikon Coolpix S10 camera (Nikon).
Morphometric analysis
To adjust brightness and contrast, all images were assembled and processed using Adobe Photoshop CS4 (Adobe Systems, San Jose, CA, USA), with no other adjustments. For morphometric image processing and analysis, digitalized captured TIFF images were transferred to ImageJ software version 1.42q (National Institutes of Health, Bethesda, MD, USA; http://imagej.nih.gov/ij/). For morphometric analysis of Brn3a(+) cell density, whole retinal microphotographs were obtained (9400) at 1 mm dorsal and ventral from the optic disk and Brn3a(+) RGC number/100 lm was assessed. For each eye, four different sections (i.e., one every 20 lm) were obtained where the ON exiting the eye was visible. Results from these sections were averaged and used as the mean value. The mean of five retinas was used as the representative value for each group. In this way, only similar retinal eccentricities were analyzed in every group, avoiding introducing bias.
ON images at 2009 magnification were processed to obtain four representative quadrants, 10 000 lm 2 each. The average immunopositive area of the four quadrants from each nerve was determined using Image J software (http://imagej.nih.gov/ij, National Institutes of Health, Bethesda, Maryland, USA). For LFB staining, the percentage of LFB per region was determined using the color threshold tool (Image J software), to avoid neutral red staining. The mean of five ONs was recorded as the representative value for each group. Data were analyzed by treatment-blind operators.
Minocycline treatment
Animals injected with vehicle in one eye and CS in the contralateral eye were randomly divided into two groups: one treated with saline solution (SS) and one treated daily (i.p.) with 30 mg/kg minocycline (Sigma-Aldrich Corp, St Louis, MO, USA). Minocycline or saline treatment started at 4 weeks of intracameral injections and continued until 6 weeks of ocular hypertension (i.e., 2-week treatment). The manner of administration and dosage of minocycline were selected on the basis of a previous report (Guasti et al. 2009 ).
Statistical analysis
Experimenters were blinded to group assignment and outcome assessment for all animal experiments. Data are presented as mean AE standard error (SE). Statistical analysis of results was performed by two-way analysis of variance (ANOVA), followed by Tukey's test. The p values below 0.05 were considered statistically significant. Sample size calculation was performed using the statistical program Infostat (FCA, University of Cordoba, Cordoba, Argentina), and the power analysis ranged between 80% and 87% for all the studies. Table 1 summarizes the average IOP from eyes injected weekly with vehicle or CS for 3, 6, 10, or 15 weeks. IOP was significantly higher in CS-than in vehicle-injected eyes at all time points examined. No significant differences in IOP values were observed between na€ ıve eyes and eyes injected with vehicle along the study (data not shown). In order to analyze the effect of CS-induced ocular hypertension on RGCs, Brn3a immunoreactivity was assessed at several time points. A significant decrease in Brn3a(+) cell number was observed in the ganglion cell layer from eyes injected with CS for 10 and 15 (but not 6) weeks, as shown in Fig. 1 .
Results
The retinal anterograde transport to the SC and LGN in na€ ıve animals and in animals in which one eye was hypertensive for 3, 6, or 15 weeks was analyzed using CTB. As shown in Fig. 2(a) , CTB labeled the entire retinotopic projection to the stratum zonale and the stratum griseum superficiale, the most superficial layers of the SC, which received projections from na€ ıve eyes. A similar profile was observed in the SC which received projections from vehicle-and CS-injected eyes for 3 weeks, whereas a reduction in CTB staining was observed in the SC which received projections from CS-injected eyes for 6 and 15 weeks of ocular hypertension. A similar profile of decrease in CTB labeling was observed in the LGN which received afferents from hypertensive eyes for 6 and 15 (but not 3) weeks (Fig. 2b) . A panoramic view of CTB staining in longitudinal sections obtained at the proximal portion of the ON from eyes injected with vehicle or CS for 6 weeks is shown in Fig. 2(c) . In ONs from eyes that were hypertensive for 6 weeks, a disruption of CTB anterograde transport occurred at the ON proximal (at 0.4-0.6 mm from the retina) myelinated portion, as indicated by MBP immunoreactivity localization in the ON from a na€ ıve eye (Fig. 2c) .
To assess the effect of ocular hypertension on the ON structure, axons, microglia, astrocytes, and the myelination state were analyzed in transverse sections of the ON proximal portion. As shown in Fig. 3 , a significant decrease in pNFH immunoreactivity was observed both at 6 and 15 weeks of ocular hypertension. No differences in pNFH(+) area were observed between ONs from eyes injected with vehicle for 6 and 15 weeks. Microglial cells were analyzed by Iba-1 and ED1 immunoreactivity (Fig. 4) . Measurement of Iba-1(+) area indicated a significant increase of this parameter at 6 weeks of CS treatment, which was lower (but still significantly higher than in control ONs) at 15 weeks of ocular hypertension. In the ON from vehicle-injected eyes, ED1 immunoreactivity was almost undetectable, whereas at 6 weeks of ocular hypertension, an increase in this parameter which progressed at 15 weeks of ocular hypertension was observed. Moreover, a significant increase in GFAP(+) area was found at 6 and 15 weeks of ocular hypertension in the proximal ON, as shown in Fig. 5(a) . Myelin alterations were assessed by LFB staining. In the proximal portion of the ON, signs of demyelination were evident at 6 weeks of ocular hypertension which progressed at 15 weeks of treatment (Fig. 5b) . No differences in Iba-1, ED1, GFAP, and pNFH immunoreactivity and LFB staining were observed between na€ ıve and vehicle-injected eyes along the study (data not shown). In order to analyze the involvement of microglial reactivity on ON alterations induced by ocular hypertension, SS or minocycline was daily administered (30 mg/kg, i.p.) for 2 weeks, starting at 4 weeks of intracameral injections of vehicle or CS. The treatment with minocycline did not affect IOP in eyes injected with vehicle or CS for 6 weeks [i.e., IOP (mmHg) was: vehicle + SS = 11.5 AE 0.9; vehicle + minocycline = 12.2 AE 0.8; CS + SS = 23.5 AE 0.9, and CS + minocycline = 22.8 AE 0.7], but it significantly prevented the increase in Iba-1(+) and ED-1(+) area induced by ocular hypertension (Fig. 6 ). In addition, minocycline prevented an increase in GFAP immunoreactivity as well as a decrease in LFB staining induced by ocular hypertension (Fig. 7) . Furthermore, the treatment with minocycline prevented the decrease in pNFH immunoreactivity induced by ocular hypertension, and preserved CTB anterograde transport from the retina to the SC and LGN (Fig. 8) .
Discussion
The present results support the involvement of microglial reactivity on the early axoglial alterations in the proximal portion of the ON induced by experimental glaucoma in rats.
Using rodent models, new insights have been gained into glaucoma pathogenesis; however, a consistent understanding of the chronology of alterations in glaucoma is still to be reached. In this sense, it is still unclear whether axon pathology initiates or follows RGC loss during glaucoma. While a body of evidence supports the former hypothesis (Howell et al. 2007; Buckingham et al. 2008; Crish et al. 2010; Calkins 2012) , other data endorse the view that atrophy of RGC soma occurs first . As shown herein, a deficit in CTB anterograde transport from the retina to the SC and LGN at 6 and 15 (but not 3) weeks of treatment with CS was observed. RGC unmyelinated axons converge at the ONH, where they exit the ocular globe and become the myelinated ON. In rats, most (~98%) fibers decussate at the optic chiasm, forming the contralateral optic tract, and synapsing in the LGN and SC (Kondo et al. 1993) . CTB is a reliable tracer that has been extensively used to analyze the communication between the retina and its synaptic targets Crish et al. 2010; Fernandez et al. 2012; Dorfman et al. 2013) . A progressive deficit in the anterograde (Crish and Calkins Fig. 2 Cholera toxin b-subunit (CTB) tracing studies. Retinal terminal projections in the superior colliculus (SC) and lateral geniculate nucleus (LGN), and CTB staining in the optic nerve (ON) from na€ ıve animals or from animals that were injected with vehicle in one eye and chondroitin sulfate (CS) in the contralateral eye. (a) Photomicrographs showing the CTB-staining pattern in the superficial layers of the SC from an animal whose eyes remained intact, and animals in which one eye was injected with vehicle and the contralateral eye received CS for 3, 6, or 15 weeks. In the SC contralateral to the eye submitted to vehicle injections for 3, 6, or 15 weeks, CTB staining was similar to that found in the SC which received projections from na€ ıve eyes. No differences in CTB staining were observed between SC receiving projections from vehicle-or CSinjected eyes for 3 weeks. In the SC contralateral to an eye with 6 weeks of ocular hypertension, a clear reduction in retinal terminal density was observed, whereas at 15 weeks of ocular hypertension a further decrease in CTB staining and zones of no staining were found. Buckingham et al. 2008) axonal transport prior to neuronal loss was previously described in some experimental models of glaucoma, and it was more recently demonstrated that anterograde transport is affected earlier and to a larger degree than retrograde transport in glaucomatous DBA/2J mice (Dengler-Crish et al. 2014 ). The present results support that experimental glaucoma provoked an early 'misconnection' between the retina and its central targets, which preceded RGC loss, and further support the axonal compartment as a specific site of early glaucomatous dysfunction. In the following experiments, we chose to wait 6 or 15 weeks of CS-induced ocular hypertension, in order to analyze pathological events at early (i.e., when anterograde transport is reduced without RGC loss) and late (i.e., after RGC loss) stages of experimental glaucoma. In order to identify the anterograde transport disruption locus along the ON in CS-induced glaucoma, intraorbital (unmyelinated and myelinated) ON sections labeled with CTB were analyzed. A disruption of CTB transport seemed to occur at the proximal, MBP(+) portion of the ON, beyond the ONH. Previous studies have shown that chronically elevated IOP disrupts retrograde axonal transport to the retina at ONH level (Martin et al. 2006; Chidlow et al. 2011) . On the other hand, both in DBA/2J mice and in a rat model of glaucoma induced by microbeads, Crish et al. (2010) reported that CTB axonal transport dysfunction and axon degeneration appear first at the SC, with a distal-proximal progression, with ONH deficits occurring much later. Currently, we do not have any explanation for this discrepancy. However, differences in animal model, species, and/or strains, as well as animal age [~8 months old DBA/2J mice and~7 months old Brown Norway rats in the report by Crish et al. (2010) and 4 months old Wistar rats in our case] could account for this disagreement. In the inbred mouse strain DBA/2J, pigmentary glaucoma is caused by an early iris atrophy and pigment dispersion that block aqueous outflow , provoking ocular hypertension through a different mechanism and with a different time frame from those involved in CS-induced ocular hypertension (Belforte et al. 2010) . On the other hand, although the treatment with microbeads induces IOP elevations of~10 mm Hg in a similar 'scenario' to that observed in CS-injected eyes, the influence of age in the former model is supported by the fact that CTB labeling in the SC was unaffected in Brown Norway rats, which received an injection of microbeads into the aqueous chamber ) at a similar age to that of Wistar rats included in the present study. In line with this, an age-related susceptibility of the rat retina to increased IOP has been demonstrated (Tan et al. 2015) . Experimental glaucoma induced by CS provoked a progressive deficit in CTB transport from the retina to the LGN (which lies anterior to the SC, i.e., more proximal to the eye) that was also diminished at an early stage of glaucoma. This result also contrasts the finding that the failure of CTB transport occurs first in the SC and then at more anterior sites in order of increasing proximity to the eye, as described by Crish et al. (2010) , and supports the occurrence of a more proximal alteration in the anterograde transport, at least in the glaucoma model induced by CS. Interestingly, we have previously shown that experimental diabetes provokes early axoglial alterations in the distal (close to the chiasm) but not proximal ON portion (Fernandez et al. 2012) , suggesting that the damage localization along the ON may show a insult type-dependent profile.
Neurofilament protein is one of the main components of the neuron cytoskeleton, it mainly distributes in neuronal soma and processes, and participates in maintaining cell normal morphology (Sihag et al. 2007) . In axons (including ON axons), almost all neurofilaments are phosphorylated, while these proteins are primarily dephosphorylated in the perikarya and dendrites (Leterrier et al. 1996) . Analysis of Iba-1(+) and ED1(+) area. At 6 weeks of ocular hypertension, a significant increase of Iba-1(+) area which was lower than that observed at 15 weeks of treatment with CS was observed. ED1 immunoreactivity was undetectable in vehicle-injected eyes for 6 or 15 weeks, whereas CS injections induced a significant increase in this parameter at 6 weeks, which was higher at 15 weeks. Data are the mean AE SEM (n = 5 ONs per group); **p < 0.01, versus vehicleinjected eyes, a: p < 0.01 versus eyes injected with CS for 6 weeks, by Tukey's test.
Phosphorylation of NFH seems to be a key mechanism in the formation of neurofilament cross-bridges, and it is deeply involved in axonal transport, axonal plasticity, and neuronal morphology (Nixon and Sihag 1991) . A decrease in NFH phosphorylation was described in prelaminar, laminar, and proximal post-laminar regions in experimental models of glaucoma in mice (Son et al. 2010) and monkeys (Kashiwagi et al. 2003) . Supporting this, a significant decrease in pNFH immunoreactivity was observed in the proximal portion of the ON from eyes with 6 or 15 weeks of ocular hypertension, which suggest that changes to the axon cytoskeleton may be involved in the axonal transport deficit induced by chronic ocular hypertension.
Microglial cells are central nervous system resident innate immune cells, endowed with sensor and effector functions, as well as phagocytic capacity during physiological and pathological conditions (reviewed by Streit et al. 2005; Perry and Teeling 2013) . These cells respond to neuronal stress or injury by adopting an activated state, in which they progress to an activated phenotype (Lee et al. 2008; Tambuyzer et al. 2009 ), which includes alterations in cellular morphology, changes in the structure of the cellular processes, redistribution, migratory characteristics, expression of various cytokines, proliferation, and phagocytic activity (Raivich and Banati 2004; Czirr and Wyss-Coray 2012) . Reactive microglia were detected in the retina and ON from axotomized eyes (Garcia-Valenzuela et al. 2005; SobradoCalvo et al. 2007) , and after ischemia/reperfusion injury (Davies et al. 2006) . In human glaucoma, there is abnormal microglial reactivity and redistribution within the ONH (Neufeld 1999; Yuan and Neufeld 2001) . Moreover, reactive microgliosis is detectable in retinas and ONs in animal (b) Analysis of Iba-1(+) and ED1(+) area. Minocycline, which showed no effect in ONs from vehicle-injected eyes, significantly decreased these parameters in ONs from hypertensive eyes. Data are mean AE SEM (n = 5 ONs per group). **p < 0.01 versus vehicleinjected eyes from animals treated with SS, a: p < 0.01 versus hypertensive eyes from animals injected with SS, by Tukey's test. models of glaucoma (Naskar et al. 2002; Son et al. 2010; Bosco et al. 2011 ). An increase in Iba-1 and ED1 immunoreactivity at the proximal ON was already evident at 6 weeks of ocular hypertension (ahead of RGC loss), supporting that microglial activation in the proximal portion of the ON may represent an early event in CS-induced experimental glaucoma. Supporting this, it was previously demonstrated that microglia become activated before RGC loss in unmyelinated and myelinated ON regions in other experimental models of glaucoma in mice (Bosco et al. 2011) and rats (Ebneter et al. 2010) . Although Iba-1(+) and ED1(+) area significantly increased in the proximal ON from glaucomatous eyes, a different profile was observed for the levels of each of these markers, since Iba-1 levels decreased from 6 to 15 weeks of ocular hypertension, while ED1 showed a change in the opposite direction, which is in agreement with the fact that Iba-1 labels both quiescent and activated microglia (providing a microglial density index), whereas the antigen ED1 represents a measure of phagocytic activity (Ebneter et al. 2010) . These results support a time of ocular hypertension-dependent progression of microglial reactivity in the proximal portion of the ON. However, since these immunohistochemical markers (Iba-1 and ED1) are also expressed in macrophages, the presence of this type of cells in the glaucomatous ON cannot be ruled out.
Besides microglial reactivity and axon alterations, astrocytosis is an index of many neurodegenerative conditions, including experimental (Zhou et al. 2009; Son et al. 2010 ; Yang et al. 2013) and human (Hernandez 2000; Kerr et al. 2011) glaucoma. Supporting this, reactive astrogliosis (as indicated by an increase in GFAP immunoreactivity) was observed in the ON proximal portion from glaucomatous eyes at early stages (i.e., 6 weeks of ocular hypertension) that persisted at late (i.e., 15 weeks of treatment with CS) stages of the experimental disease. Oligodendrocyte death in the ON preceding RGC loss has been shown in laser-induced ocular hypertension in mice (Nakazawa et al. 2006) . Supporting this, at 6 weeks of CSinduced ocular hypertension, a slight (but significant) decrease in LFB staining, which progressed at 15 weeks of treatment, was observed. In contrast, in DBA/2J mouse and in a rat ocular hypertension model, Son et al. (2010) have shown a modest loss of oligodendrocytes that occurs after axons had already degenerated. Therefore, the early myelin alterations shown in some experimental models of glaucoma may not be generalized to others. In the CS-induced model of glaucoma, the early decrease in LFB staining was concomitant with a decrease in anterograde transport and pNFH immunoreactivity, astrocytosis, and increased microglial reactivity. Thus, although we could not determine whether the early damage provoked by CS-induced glaucoma primarily affected axons or glial cells, our results suggest that the reciprocal communication between axons and glia in the proximal ON can be negatively regulated at early stages of the experimental disease.
Microglial reactivity is a common feature of neurological disorders. In order to analyze whether it contributes to neuronal and/or glial damage, we analyzed the effect of minocycline on early axoglial alterations of the proximal portion of the ON induced by ocular hypertension. Minocycline, which crosses the blood-brain barrier, is an inhibitor of microglial activation in the retina . Moreover, minocycline delays the death of axotomized RGCs by inhibiting microglia activation (Baptiste et al. 2005) , and it reduces retinal microglia activation, and improves ON integrity in glaucomatous DBA/2J mice (Bosco et al. 2008) . As expected, the treatment with minocycline significantly prevented the increase in Iba-1 and ED-1 immunoreactivity in the proximal portion of the ON from eyes that were hypertensive for 6 weeks. Moreover, a 2-week treatment with minocycline significantly prevented the decrease in pNFH and the increase in GFAP immunoreactivity, as well as the decrease in LFB staining. Supporting this, it was shown that inhibition of microglial activation with minocycline leads to a decrease of astrogliosis in mouse hippocampus induced by heat stress (Lee et al. 2015) and cuprizone-induced demyelination (Pasquini et al. 2007) .
Concurrently with the structural preservation, minocycline also preserved the anterograde transport of CTB from the retina to the SC and LGN. Therefore, although a more detailed temporal course of proximal ON microglial reactivity (particularly, before and after 6 weeks of ocular hypertension) deserves to be analyzed, the present results support the involvement of microglial reactivity in axoglial alterations in the proximal portion of the ON and, in turn, in the misconnection between the retina and its synaptic targets induced by experimental glaucoma.
Axonal damage often results in axonal degeneration and permanent loss of the cell body. ON transection or crush induce a rapid stress response in RGCs that finally results in neuronal death You et al. 2012) . Therefore, although in the present report, the effect of minocycline was assessed at early stages of glaucoma (before RGC loss), it seems likely that the axonal protection conferred by minocycline could account for its protective effect on RGCs demonstrated in other experimental models of glaucoma (Levkovitch-Verbin et al. 2006 Wang et al. 2014) , and that the restoration of anterograde transport along RGC axons and the prevention of axoglial alterations in the proximal ON might be early therapeutic targets for glaucoma treatment.
Conclusions
The significance of this observation, if confirmed in the human condition, supports the targeting of ON microglial reactivity to prevent early axoglial alterations in the proximal ON and consequently, to slow the progression of glaucoma.
